MAPT and Alzheimer disease: Other biomarkers such as pT205 [73], pS235 [74], brain‐derived tau‐specific isoforms [75], N‐terminal tau [76, 77, 78, 79, 80], and midfragments of tau in CSF [81] are also expected to serve as AD biomarkers.